ClinicalTrials.Veeva

Menu

Effects of Dıfferent Tournıques and Posıtıons on Paın, Anxıety Levels and Applıcatıon Success in Perıpheral Intravenous Catheter Applıcatıon: a Randomızed Controlled Study (CATHETER)

I

Istanbul University - Cerrahpasa

Status

Completed

Conditions

Tourniquets
INTRAVENOUS CATHETER APPLICATION

Treatments

Other: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT06862921
Clinical Research Ethics Commi (Registry Identifier)
Uskudar University

Details and patient eligibility

About

Aim:

The aim of this study was to investigate the effect of different tourniquet and position on pain, anxiety level and success of peripheral intravenous catheter (PIC) application.

Design:

Randomized controlled experimental design.

Full description

Aim:

The aim of this study was to investigate the effect of different tourniquet and position on pain, anxiety level and success of peripheral intravenous catheter (PIC) application.

Primary purpose:investigate the effect of different tourniquet and position on pain, Secondary purpose:investigate the effect of different tourniquet and position on anxiety level and success of peripheral intravenous catheter (PIC) application.

Design:

Randomized controlled experimental design.

Methods:

The randomized controlled experimental design study was conducted with 110 adult patients in the orthopedic department of a Training and Research Hospital between May 2024 and July 2024. Data were collected using the Patient Information Form, Visual Infusion Phlebitis Diagnostic Scale, Infiltration Scale, Visual Pain Scale, and Facial Anxiety Scale. PIC was applied to patients in the "Experimental Group 1" using a standard tourniquet in the supine position, to patients in the "Experimental Group 2" using a sphygmomanometer at 60 mmHg pressure in the fawler position, and to patients in the "Experimental Group 3" using a sphygmomanometer at 60 mmHg pressure in the supine position. In the control group, a peripheral intravenous catheter was applied in the fawler position using a standard tourniquet. Patients were asked to evaluate the level of pain and anxiety before and after the application. The patients were followed up for phlebitis and extravasation findings at eight-hour intervals after the application. Except for complications requiring removal of the peripheral intravenous catheter during follow-up, the PIC was removed 96 hours after application. The results were evaluated at 95% confidence intervals with a significance level of p ≤ 0.05.

Enrollment

110 patients

Sex

All

Ages

18 to 64 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patient

    1. Volunteering to participate in the research

    2. Be between the ages of 18-64,

    3. The planned length of hospitalization is not less than 96 hours.

      Exclusion Criteria:

      In the patient

    <!-- -->
    1. Coagulation, hematologic and hydration problems

    2. Oncological, allergic diseases, any incision or scar tissue in the antecubital area, presence of complications due to a previously opened catheter, presence of pain, hematoma, ecchymosis in the application area, or presence of any other injection in the antecubital area on treatment days,

    3. The presence of an obstacle (such as mastectomy) in the arm to be treated.

      Expulsion criteria from the study:

    <!-- -->
    1. Dislodgement of the peripheral intravenous catheter for any reason.
    2. Failure of peripheral intravenous catheter placement more than twice.
    3. Discharge of the patient from the hospital.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

None (Open label)

110 participants in 3 patient groups

Experimental Group 1
Experimental group
Description:
standard tourniquet in the supine position
Treatment:
Other: Control
Experimental Group 2
Experimental group
Description:
sphygmomanometer at 60 mmHg pressure in the fawler position
Treatment:
Other: Control
Experimental Group 3
Experimental group
Description:
sphygmomanometer at 60 mmHg pressure in the supine position
Treatment:
Other: Control

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems